Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.12.2014 | editorial

International MDS Working Groups: a model of success to improve diagnosis and treatment in rare diseases: 10-year jubilee of the Austrian MDS platform

verfasst von: Univ.-Prof. Dr. Michael Pfeilstöcker, MBA

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Excerpt

The year 2013 marked the 10th anniversary of the Myelodysplastic Syndromes (MDS) Platform of the Austrian Society for Hematology and Oncology. Although there had already been previously scientific contributions to this field, in 2003, the founding members of the platform concluded that combined efforts of all MDS researchers in Austria would promote the outcome and recognition of this work and improve clinical management of MDS patients. To celebrate this anniversary, an educational meeting in November 2013 provided a “state of the art” overview in MDS and was also a good opportunity to analyze the benefits of collaborative work and to plan future projects. …
Vorheriger Artikel Angiogenesis
Nächster Artikel ASCO 2014: news, hopes, hypes?
Literatur
1.
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65. PubMed PMID: 22740453.
2.
Nösslinger T, Tüchler H, Germing U, Sperr WR, Krieger O, Haase D, Lübbert M, Stauder R, Giagounidis A, Valent P, Pfeilstöcker M. Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes. Ann Oncol. 2010;21(1):120–5. doi:10.1093/annonc/mdp264. PubMed PMID: 19605511.
3.
Pleyer L, Burgstaller S, Girschikofsky M, Linkesch W, Stauder R, Pfeilstöcker M, Schreder M, Tinchon C, Sliwa T, Lang A, Sperr WR, Krippl P, Geissler D, Voskova D, Schlick K, Thaler J, Machherndl-Spandl S, Theiler G, Eckmüllner O, Greil R. Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group. Ann Hematol. 2014 June 21. Epub ahead of print. PubMed PMID: 24951123.
4.
Stauder R, Nösslinger T, Pfeilstöcker M, Sperr WR, Wimazal F, Krieger O, Valent P. Impact of age and comorbidity in myelodysplastic syndromes. J Natl Compr Canc Netw. 2008;6(9):927–34. Review. PubMed PMID: 18926101.
5.
Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res. 2007;31(6):727–36. Review. PubMed PMID: 17257673.
6.
Stauder R, Wimazal F, Nösslinger T, Krieger O, Sperr WR, Sill H, Pfeilstöcker M, Valent P. [Individualized management and therapy of myelodysplastic syndromes]. Wien Klin Wochenschr. 2008;120(17–18):523–37. Review. German. doi:10.1007/s00508-008-1058-6. PubMed PMID: 18988005.
Metadaten
Titel
International MDS Working Groups: a model of success to improve diagnosis and treatment in rare diseases: 10-year jubilee of the Austrian MDS platform
verfasst von
Univ.-Prof. Dr. Michael Pfeilstöcker, MBA
Publikationsdatum
01.12.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0167-3

Weitere Artikel der Ausgabe 4/2014

Melanoma 2014—an update

  • short review

Contribution of the vascular bone marrow niche to leukemia progression

  • short review

Gene signature profiling of gynaecological malignancies

  • short review

Angiogenesis in myeloproliferative neoplasms, new markers and future directions

  • Open Access
  • short review

Towards automation of flow cytometric analysis for quality-assured follow-up assessment to guide curative therapy for acute lymphoblastic leukaemia in children

  • special report

ASCO 2014: news, hopes, hypes?

  • editorial